Two of the most studied proton transporters in breast cancer are V-ATPases and NHE1, whose aberrant activity contributes to create a reversed pH gradient that promotes mammary tumor growth and invasiveness [34,35,36]. This evidence concerns the gene SLC9A1 and breast cancer.